
Babak Tousi MD FACP
Dementia
Head, Clinical Trials Program, Cleveland Clinic Lou Ruvo Center for Brain Health- Cleveland. Associate Professor of Neurology and Medicine
Join to View Full Profile
- 9500 Euclid Ave U-10Cleveland, OH 44195 
- Phone+1 216-636-9467 
- Fax+1 216-636-2645 
Dr. Tousi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Babak Tousi is a neurogeriatrician in Cleveland, OH and is affiliated with Cleveland Clinic. He received his medical degree from Tehran University of Medical Sciences School of Medicine and has been in practice 23 years. He is experienced in movement disorders, dementia, alzheimer's disease, parkinson's disease, and lewy body dementia.
Education & Training
 Cleveland Clinic FoundationFellowship, Movement Disorders - Neurology, 2003 - 2005 Cleveland Clinic FoundationFellowship, Movement Disorders - Neurology, 2003 - 2005
 Cleveland Clinic FoundationFellowship, Geriatric Medicine (Internal Medicine), 2002 - 2003 Cleveland Clinic FoundationFellowship, Geriatric Medicine (Internal Medicine), 2002 - 2003
 Atlantic Health System/Morristown Medical CenterResidency, Internal Medicine, 1999 - 2002 Atlantic Health System/Morristown Medical CenterResidency, Internal Medicine, 1999 - 2002
 Tehran University of Medical Sciences School of MedicineClass of 1995, M.D. Tehran University of Medical Sciences School of MedicineClass of 1995, M.D.
Certifications & Licensure
 OH State Medical License 2002 - 2027 OH State Medical License 2002 - 2027
 American Board of Internal Medicine Geriatric Medicine American Board of Internal Medicine Geriatric Medicine
Awards, Honors, & Recognition
- Jennifer B Langston Community Award Alzheimer's Association, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease Start of enrollment: 2012 Apr 19
- Effect of NeuroAD on the Cognitive Function of Alzheimer Patients Start of enrollment: 2013 Oct 01
- Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil Start of enrollment: 2014 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus.Valerie Rico, Megan Zelinsky, Paul J Ford, James Leverenz, Jagan A Pillai
 Journal of Alzheimer's Disease. 2025-09-25
- 2 citationsEfficacy and safety of passive immunotherapies targeting amyloid beta in Alzheimer's disease: A systematic review and meta-analysis.Reina Tonegawa-Kuji, Yuan Hou, Bo Hu, Noah Lorincz-Comi, Andrew A Pieper
 Plos Medicine. 2025-03-01
- 1 citationsBuilding expert consensus regarding sharing of individual research results in Alzheimer's disease research: a Delphi study protocol.Lauren R Sankary, Valerie Rico, Megan Zelinsky, Helen S Webster, Alan J Lerner
 BMJ Open. 2024-08-24
Books/Book Chapters
Press Mentions
 Cleveland Alzheimer's Conference to Offer Early Detection Education, Caregiver AdviceJuly 7th, 2025 Cleveland Alzheimer's Conference to Offer Early Detection Education, Caregiver AdviceJuly 7th, 2025
 Can Semaglutide Prevent Alzheimer’s?June 19th, 2025 Can Semaglutide Prevent Alzheimer’s?June 19th, 2025
 New Alzheimer’s Drug Approved in Great BritainAugust 22nd, 2024 New Alzheimer’s Drug Approved in Great BritainAugust 22nd, 2024
- Join now to see all
Professional Memberships
- Member
- Fellow
- Alzheimer's AssociationScientific Advisory Board Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









